, Treatment of IgA nephropathy, Kidney International, vol.69, issue.11, pp.1934-1938, 2006.
DOI : 10.1038/sj.ki.5000419
, IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors, Nature Clinical Practice Nephrology, vol.41, issue.1, pp.24-31, 2006.
DOI : 10.1038/ncpneph0055
, Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis, Nephrology Dialysis Transplantation, vol.26, issue.10, pp.3131-3143, 2011.
DOI : 10.1093/ndt/gfr096
, Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis, AJP: Renal Physiology, vol.294, issue.4, pp.801-811, 2008.
DOI : 10.1152/ajprenal.00148.2007
, Addition of the Antioxidant Probucol to Angiotensin II Type I Receptor Antagonist Arrests Progressive Mesangioproliferative Glomerulonephritis in the Rat, Journal of the American Society of Nephrology, vol.17, issue.3, pp.783-794, 2006.
DOI : 10.1681/ASN.2005050519
, Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis, Kidney International, vol.68, issue.6, pp.2714-2725, 2005.
DOI : 10.1111/j.1523-1755.2005.00742.x
, Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis, Kidney International, vol.55, issue.3, pp.877-889, 1999.
DOI : 10.1046/j.1523-1755.1999.055003877.x
, Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure, Nephrology Dialysis Transplantation, vol.20, issue.11, pp.2358-2367, 2005.
DOI : 10.1093/ndt/gfi062
, Mechanisms Underlying the Ameliorative Property of Lisinopril in Progressive Mesangioproliferative Nephritis, Nephron, vol.91, issue.4, pp.719-729, 2002.
DOI : 10.1159/000065036
, Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril, AJP: Renal Physiology, vol.289, issue.2, pp.359-368, 2005.
DOI : 10.1152/ajprenal.00442.2004
, Spironolactone in Combination with Cilazapril Ameliorates Proteinuria and Renal Interstitial Fibrosis in Rats with Anti-Thy-1 Irreversible Nephritis, Hypertension Research, vol.27, issue.12, pp.971-978, 2004.
DOI : 10.1291/hypres.27.971
, A New Look at Platelet-Derived Growth Factor in Renal Disease, Journal of the American Society of Nephrology, vol.19, issue.1, pp.12-23, 2008.
DOI : 10.1681/ASN.2007050532
, Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimental Glomerulonephritis, Journal of the American Society of Nephrology, vol.17, issue.4, pp.1054-1062, 2006.
DOI : 10.1681/ASN.2005070683
, A Fully Human Monoclonal Antibody (CR002) Identifies PDGF-D as a Novel Mediator of Mesangioproliferative Glomerulonephritis, Journal of the American Society of Nephrology, vol.14, issue.9, pp.2237-2247, 2003.
DOI : 10.1097/01.ASN.0000083393.00959.02
, Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis, J Am Soc Nephrol, vol.12, pp.909-918, 2001.
, Comparison of Simultaneous Measurements of Blood Pressure by Tail-Cuff and Carotid Arterial Methods in Conscious Spontaneously Hypertensive and Wistar-Kyoto Rats, Clinical and Experimental Hypertension, vol.278, issue.1, pp.57-72, 2006.
DOI : 10.1161/01.RES.0000012460.85923.F0
, Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines, Kidney International, vol.66, issue.1, pp.91-101, 2004.
DOI : 10.1111/j.1523-1755.2004.00711.x
, Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention, Journal of the American Society of Nephrology, vol.15, issue.1, pp.1-12, 2004.
DOI : 10.1097/01.ASN.0000106015.29070.E7
, Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies, Kidney International, vol.62, issue.1, pp.137-146, 2002.
DOI : 10.1046/j.1523-1755.2002.00430.x
, Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D, Kidney International, vol.80, issue.12, pp.1292-1305, 2011.
DOI : 10.1038/ki.2011.278
, Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b, Theoretical Biology and Medical Modelling, vol.3, issue.1, pp.1-33, 2006.
DOI : 10.1186/1742-4682-3-1
, Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR??-Modulating Activity, Hypertension, vol.43, issue.5, pp.993-1002, 2004.
DOI : 10.1161/01.HYP.0000123072.34629.57
, Mechanisms of angiotensin II signaling on cytoskeleton of podocytes, Journal of Molecular Medicine, vol.18, issue.12, pp.1379-1394, 2008.
DOI : 10.1007/s00109-008-0399-y
, Angiotensin-Converting Enzyme Inhibition Abolishes Medial Smooth Muscle PDGF-AB Biosynthesis and Attenuates Cell Proliferation in Injured Carotid Arteries : Relationships to Neointima Formation, Circulation, vol.96, issue.5, pp.1631-1640, 1997.
DOI : 10.1161/01.CIR.96.5.1631
, Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats, Kidney International, vol.49, issue.3, pp.666-678, 1996.
DOI : 10.1038/ki.1996.95
, Obstructive Uropathy in Mice and Humans: Potential Role for PDGF-D in the Progression of Tubulointerstitial Injury, Journal of the American Society of Nephrology, vol.14, issue.10, pp.2544-2555, 2003.
DOI : 10.1097/01.ASN.0000089828.73014.C8
, PDGF-C Is a Proinflammatory Cytokine that Mediates Renal Interstitial Fibrosis, Journal of the American Society of Nephrology, vol.19, issue.2, pp.281-289, 2008.
DOI : 10.1681/ASN.2007030290
, The CC chemokine CCL20 and its receptor CCR6, Cytokine & Growth Factor Reviews, vol.14, issue.5, pp.409-426, 2003.
DOI : 10.1016/S1359-6101(03)00049-2